Latest filing published 09 May 2019 for Milestone Pharmaceuticals Inc., €2.7M.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
BDC Capital Inc.: trading record in brief
BDC Capital Inc. has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Ocera Therapeutics, Inc. and Milestone Pharmaceuticals Inc. We count 5 filings; the first trade dates from 6 April 2011 and the latest from 8 May 2019.
Every open-market trade on record is a purchase: 2 purchases worth €5.5M, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2019: 1 purchase and no sales on the market.
Most recently, on 9 May 2019, the filings show an open-market purchase worth €2.7M in Milestone Pharmaceuticals Inc. The median gap between trade and publication is zero days: most filings appear on the same day. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to BDC Capital Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 200,000 shares@ US$15.00Common SharesSEC:0000930413-19-001627:0Canonical exit: 6 Aug 2019 (T+90)
- 307,287 sharesCommon StockSEC:0001104659-11-018941:0
- 16,108 sharesCommon StockSEC:0001104659-11-018941:1
- 1,000,000 shares@ US$4.00Common StockSEC:0001104659-11-018941:3Canonical exit: 5 Jul 2011 (T+90)
- 915,430 sharesCommon StockSEC:0001104659-11-018941:2
5 of 5 declarations
